Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Röth A, Berentsen S, Barcellini W, D'Sa S, Jilma B, Michel M, Weitz IC, Yamaguchi M, Nishimura JI, Vos JMI, Storek M, Wong N, Patel P, Jiang X, Vagge DS, Wardęcki M, Shafer F, Lee M, Broome CM.
Röth A, et al. Among authors: jilma b.
Blood. 2022 Sep 1;140(9):980-991. doi: 10.1182/blood.2021014955.
Blood. 2022.
PMID: 35687757
Free PMC article.
Clinical Trial.